Workflow
非公开发行A股股票
icon
Search documents
恒立液压: 中国国际金融股份有限公司关于江苏恒立液压股份有限公司2021年度非公开发行A股股票持续督导保荐总结报告书
Zheng Quan Zhi Xing· 2025-05-13 08:21
Core Viewpoint - Jiangsu Hengli Hydraulic Co., Ltd. successfully completed a non-public offering of 35,460,992 shares at a price of 56.40 RMB per share, raising a total of approximately 1.99 billion RMB in net funds [1][2]. Group 1: Company Overview - Jiangsu Hengli Hydraulic Co., Ltd. was established on June 2, 2005, with a registered capital of 1,340,820,992 RMB [1]. - The company specializes in the research, production, and technical support of high-pressure cylinders, hydraulic components, hydraulic systems, high-pressure plunger pumps and motors, high-pressure hydraulic valves, and precision castings [1]. Group 2: Sponsorship and Supervision - China International Capital Corporation (CICC) served as the sponsor for Hengli Hydraulic's non-public offering and is responsible for ongoing supervision [1][2]. - The sponsorship period for the non-public offering will conclude on December 31, 2024, and CICC will continue to oversee the remaining use of raised funds [4]. Group 3: Due Diligence and Compliance - During the due diligence phase, CICC conducted thorough investigations and prepared necessary documentation in compliance with regulations set by the China Securities Regulatory Commission (CSRC) and the Shanghai Stock Exchange [2]. - Throughout the ongoing supervision phase, Hengli Hydraulic adhered to legal and regulatory requirements, ensuring timely and accurate information disclosure [3]. Group 4: Fund Management - The company has complied with regulations regarding the management of raised funds, maintaining dedicated accounts for storage and specific usage [3]. - As of December 31, 2024, there are still some unutilized funds from the raised capital, and CICC will continue to monitor their usage [4].
麦迪科技: 申万宏源证券承销保荐有限责任公司关于苏州麦迪斯顿医疗科技股份有限公司2022年非公开发行A股股票之保荐工作总结报告书
Zheng Quan Zhi Xing· 2025-05-12 13:31
申万宏源证券承销保荐有限责任公司 关于苏州麦迪斯顿医疗科技股份有限公司 保荐工作总结报告书 申万宏源证券承销保荐有限责任公司(以下简称"申万宏源承销保荐"、 "保 荐机构")作为苏州麦迪斯顿医疗科技股份有限公司(以下简称"公司"或"麦 迪科技")2022年非公开发行股票的保荐机构,持续督导期间为2023年1月3日至 券发行上市保荐业务管理办法》、《上海证券交易所上市公司自律监管指引第11 号——持续督导》、 《上海证券交易所股票上市规则》等相关法律法规文件要求, 申万宏源承销保荐现出具保荐工作总结报告书,具体内容如下: 一、保荐机构及保荐代表人承诺 误导性陈述或重大遗漏,保荐机构及保荐代表人对其真实性、准确性、完整性承 担法律责任。 进行的任何质询和调查。 理办法》及上海证券交易所(以下简称"上交所")按照《上海证券交易所上市公 司自律监管指引第11号——持续督导》等有关规定采取的监管措施。 二、保荐机构基本情况 保荐机构名称 申万宏源证券承销保荐有限责任公司 新疆乌鲁木齐市高新区(新市区)北京南路358号大 注册地址 | | 成国际大厦20楼2004室 | | --- | --- | | 法定代表人 | 王 ...